BillionToOne vs Natera
BLLN and NTRA side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BLLN and NTRA compare
Natera is the larger company, worth 9.0 times as much as BillionToOne ($41.4B against $4.6B).
BillionToOne grew revenue faster over the last twelve months (71.9% versus 37.8% for Natera).
BillionToOne keeps more of each dollar of sales as profit, with a net margin of 11.3% compared with −7.1% at Natera.
BillionToOne scores higher on the StockData Score (11 against 10 for Natera), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BLLN | NTRA |
|---|---|---|
| Size and price | ||
| Market cap | $4.6B | $41.4B |
| Share price | $97.50 | $287.47 |
| Change, 1 year | 8.3% | 40.7% |
| Change, 5 years | – | 204% |
| Beta (5Y) | 0.38 | 1.81 |
| Employees | 713 | 6,140 |
| StockData Score | ||
| Total score | 11 (better) | 10 |
| Valuation score | 0 | 0 |
| Growth score | 3 | 3 |
| Performance score | 2 | 2 |
| Health score | 6 (better) | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 10.5× (better) | 15.3× |
| P/B | 8.1× (better) | 22.7× |
| EV/EBITDA | 77.8× | – |
| P/FCF | 136× (better) | 492× |
| FCF yield | 0.74% (better) | 0.20% |
| Fair value | – | $120.81 |
| Margin of safety | – | −138% |
| Growth | ||
| Revenue growth (TTM) | 71.9% (better) | 37.8% |
| Revenue growth, 5Y average | – | 42.6% |
| Profitability | ||
| Gross margin | 71.4% | – |
| Operating margin | 10.2% (better) | −10.7% |
| Net margin | 11.3% (better) | −7.1% |
| FCF margin | 7.8% (better) | 3.1% |
| Return on equity | 30.2% (better) | −12.5% |
| Return on invested capital | – | −40.8% |
| Financial health | ||
| Debt / equity | 0.00 | 0.04 (better) |
| Interest coverage | 1655× (better) | −75.9× |
| Current ratio | 11.25 (better) | 3.00 |
| Altman Z-score | 15.56 | 29.36 (better) |
| Piotroski F-score | 8 (better) | 5 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 32.4% | 95.2% |
| Held by insiders | 55.7% | 3.9% |
| Insider net buying, 12 months | −$58.5M (better) | −$342M |
| Superinvestors holding | – | 3 |
| Short interest, % of float | 14.2% | 4.4% |
Go deeper
- BLLN stock overview
- BLLN income statement
- BLLN valuation and score
- NTRA stock overview
- NTRA income statement
- NTRA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.